MedPath

Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS) FI

Completed
Conditions
Cardiovascular Diseases
Heart Failure
Heart Diseases
Registration Number
NCT04444583
Lead Sponsor
Precordior Ltd
Brief Summary

In this study the ability of smartphone sensors (accelerometer and gyroscope) to identify patients with heart failure will be studied.

Detailed Description

Heart Failure (HF) is a condition where heart is unable to maintain adequate volume of blood in circulation corresponding to prevailing physiological demand. Gyrocardiography is a technique that utilizes micro electromechanical sensors (MEMS), accelerometer and gyroscope, to detect vibrations and rotation of thorax caused by cardiac motion. The main purpose of this study is to test the ability of an app of a smartphone with embedded motion sensors, positioned on the chest which measures the movements and function of the heart, to identify patients with different types of heart failure and their characteristics, as compared with clinical diagnosis. Echocardiography will also be used to confirm changes in cardiac cardiac mechanics including strain, cardiac torsion, diastolic filling characteristics.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
155
Inclusion Criteria
  • Age >18 years
  • Patients visiting hospital for heart failure, either outpatient clinic or cardiac ward
  • Signed informed consent as an acceptance to participate to the trial
Exclusion Criteria
  • Age <18 years

    • Severe cardiac valve disease
    • Previous prosthetic cardiac valve
    • Major adverse cardiovascular event or surgery within 6 weeks of planned study enrollment
    • Patients with pacemaker
    • Informed consent form not signed.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HF specific motion sensor characteristics validation against echocardiography and other clinical featuresFrom the hospital admission to study closure visit, on average 15 weeks

The study aims to validate HF specific characteristics obtained with accelerometer (m/s2) and gyroscope (degree/s) against the current gold standard, detailed echocardiography examination in individuals already diagnosed with HF. Data of anonymised subjects without diagnosed or suspected HF will be used as controls to study the detection of HF.

Secondary Outcome Measures
NameTimeMethod
HF decompensation specific motion sensor characteristics validation14 weeks

The ability of the motion sensors to detect differences in myocardial mechanics in patients with decompensation episode compared to patients without decompensation episode, assessed by receiver operating characteristics (ROC).

Trial Locations

Locations (2)

Heart and Lung Center at Helsinki University Hospital

🇫🇮

Helsinki, Finland

Heart Center at Turku University Hospital

🇫🇮

Turku, Finland

Heart and Lung Center at Helsinki University Hospital
🇫🇮Helsinki, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.